| Descriptor English: | Neuro-Oncological Ventral Antigen | ||||||
| Descriptor Spanish: |
Antígeno Ventral Neuro-Oncológico
| ||||||
| Descriptor Portuguese: | Antígeno Neuro-Oncológico Ventral | ||||||
| Descriptor French: | Neuro-oncological ventral antigen | ||||||
| Entry term(s): |
1, Nova Antigen, Neuro-Oncological Ventral Antigen, Nova Antigen, Nova-1 Antigen, Paraneoplastic Ri Antigen, Ri Antigens, Ri Neuro Oncological Ventral Antigen Neuro Oncological Ventral Antigen 2 Neuro-Oncological Ventral Antigen 1 Neuro-Oncological Ventral Antigen 2 Nova 1 Nova 1 Antigen Nova Antigen Nova Protein Nova-1 Antigen Paraneoplastic Ri Antigen Paraneoplastic Ri Antigen, 55 KDA Protein, Nova Ri Antigen Ri Antigen, Paraneoplastic Ri Antigens Ventral Neuron Specific Protein 1 Ventral Neuron-Specific Protein 1 |
||||||
| Tree number(s): |
D12.776.157.725.441 D12.776.631.611 D12.776.664.962.448 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000090682 | ||||||
| Scope note: | They are RNA-BINDING PROTEINS involved in mRNA processing. These are essential in gene regulation, including splicing, translation, transport, stability, and degradation of RNA. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2022; NOVA ANTIGEN was indexed under ANTIGENS, NEOPLASM 1993-2017, RIBONUCLEOPROTEINS 1993-2002, NERVE TISSUE PROTEINS 1993-2021, and RNA-BINDING PROTEINS 1993-2021 |
||||||
| History Note: | 2022 (1993) |
||||||
| DeCS ID: | 59813 | ||||||
| Unique ID: | D000090682 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2022/01/01 | ||||||
| Date of Entry: | 2021/07/09 | ||||||
| Revision Date: | 2021/06/29 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Neuro-Oncological Ventral Antigen
- Preferred
Neuro-Oncological Ventral Antigen 2
- Narrower
Neuro-Oncological Ventral Antigen 1
- Narrower
| Concept UI |
M000747067 |
| Scope note | They are RNA-BINDING PROTEINS involved in mRNA processing. These are essential in gene regulation, including splicing, translation, transport, stability, and degradation of RNA. |
| Preferred term | Neuro-Oncological Ventral Antigen |
| Entry term(s) |
Antigen, Neuro-Oncological Ventral Antigen, Nova Antigen, Paraneoplastic Ri Antigen, Ri Antigens, Ri Neuro Oncological Ventral Antigen Nova Antigen Nova Protein Paraneoplastic Ri Antigen Paraneoplastic Ri Antigen, 55 KDA Protein, Nova Ri Antigen Ri Antigen, Paraneoplastic Ri Antigens |
| Concept UI |
M000749607 |
| Preferred term | Neuro-Oncological Ventral Antigen 2 |
| Entry term(s) |
Neuro Oncological Ventral Antigen 2 |
| Concept UI |
M0222801 |
| Scope note | A neuron-specific in expression RNA-BINDING PROTEIN, involved in neurological disorders and cancer. Known as a target antigen in paraneoplastic motor disorder. |
| Preferred term | Neuro-Oncological Ventral Antigen 1 |
| Entry term(s) |
1, Nova Antigen, Nova-1 Nova 1 Nova 1 Antigen Nova-1 Antigen Ventral Neuron Specific Protein 1 Ventral Neuron-Specific Protein 1 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
